Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of JTT-751 in Hemodialysis Patients
jRCT2080221398Phase 3
- Sponsor
- Japan Tobacco
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferric citrate in end-stage kidney disease (ESKD), sponsored by Japan Tobacco.
02
Drugs
ferric citrate
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on jRCT2080221398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221398.